Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(4)
Other(5)

Detailed Status

unknown5
Completed4
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (9.1%)
N/A10 (90.9%)

Trials by Status

unknown545%
completed436%
active_not_recruiting19%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11